ID   A904L
AC   CVCL_U095
DR   RCB; RCB3531
DR   TOKU-E; 3583
DR   Wikidata; Q54607542
RX   PubMed=11267941;
RX   PubMed=12114371;
RX   PubMed=15994973;
RX   PubMed=16651449;
RX   PubMed=17131342;
RX   PubMed=17511773;
RX   PubMed=17725806;
RX   PubMed=19799608;
RX   PubMed=38639832;
CC   Population: Chinese; Han and Korean.
CC   HLA typing: A*24:02; B*07:02; C*07:02 (PubMed=12114371).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5AL ! A904-EBV-B
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 13
//
RX   PubMed=11267941; DOI=10.1111/j.1349-7006.2001.tb01096.x; PMCID=PMC5926714;
RA   Takenoyama M., Yoshino I., Eifuku R., So T., Imahayashi S., Sugaya M.,
RA   Yasuda M., Inoue M., Ichiyoshi Y., Osaki T., Nagashima A., Nomoto K.,
RA   Yasumoto K.;
RT   "Successful induction of tumor-specific cytotoxic T lymphocytes from
RT   patients with non-small cell lung cancer using CD80-transfected
RT   autologous tumor cells.";
RL   Jpn. J. Cancer Res. 92:309-315(2001).
//
RX   PubMed=12114371; DOI=10.1378/chest.122.1.282;
RA   Sugaya M., Takenoyama M., Osaki T., Yasuda M., Nagashima A., Sugio K.,
RA   Yasumoto K.;
RT   "Establishment of 15 cancer cell lines from patients with lung cancer
RT   and the potential tools for immunotherapy.";
RL   Chest 122:282-288(2002).
//
RX   PubMed=15994973; DOI=10.1158/0008-5472.CAN-04-3787;
RA   So T., Takenoyama M., Mizukami M., Ichiki Y., Sugaya M., Hanagiri T.,
RA   Sugio K., Yasumoto K.;
RT   "Haplotype loss of HLA class I antigen as an escape mechanism from
RT   immune attack in lung cancer.";
RL   Cancer Res. 65:5945-5952(2005).
//
RX   PubMed=16651449; DOI=10.1158/0008-5472.CAN-05-3840;
RA   Fukuyama T., Hanagiri T., Takenoyama M., Ichiki Y., Mizukami M.,
RA   So T., Sugaya M., So T., Sugio K., Yasumoto K.;
RT   "Identification of a new cancer/germline gene, KK-LC-1, encoding an
RT   antigen recognized by autologous CTL induced on human lung
RT   adenocarcinoma.";
RL   Cancer Res. 66:4922-4928(2006).
//
RX   PubMed=17131342; DOI=10.1002/ijc.22396;
RA   Sugaya M., Takenoyama M., Shigematsu Y., Baba T., Fukuyama T.,
RA   Nagata Y., Mizukami M., So T., Ichiki Y., Yasuda M., So T.,
RA   Hanagiri T., Sugio K., Yasumoto K.;
RT   "Identification of HLA-A24 restricted shared antigen recognized by
RT   autologous cytotoxic T lymphocytes from a patient with large cell
RT   carcinoma of the lung.";
RL   Int. J. Cancer 120:1055-1062(2007).
//
RX   PubMed=17511773; DOI=10.1111/j.1349-7006.2007.00507.x; PMCID=PMC11159702;
RA   Fukuyama T., Ichiki Y., Yamada S., Shigematsu Y., Baba T., Nagata Y.,
RA   Mizukami M., Sugaya M., Takenoyama M., Hanagiri T., Sugio K.,
RA   Yasumoto K.;
RT   "Cytokine production of lung cancer cell lines: correlation between
RT   their production and the inflammatory/immunological responses both in
RT   vivo and in vitro.";
RL   Cancer Sci. 98:1048-1054(2007).
//
RX   PubMed=17725806; DOI=10.1111/j.1349-7006.2007.00586.x; PMCID=PMC11159108;
RA   Baba T., Hanagiri T., Ichiki Y., Kuroda K., Shigematsu Y.,
RA   Mizukami M., Sugaya M., Takenoyama M., Sugio K., Yasumoto K.;
RT   "Lack and restoration of sensitivity of lung cancer cells to cellular
RT   attack with special reference to expression of human leukocyte
RT   antigen class I and/or major histocompatibility complex class I chain
RT   related molecules A/B.";
RL   Cancer Sci. 98:1795-1802(2007).
//
RX   PubMed=19799608; DOI=10.1111/j.1349-7006.2009.01351.x; PMCID=PMC11159900;
RA   Kuroda K., Takenoyama M., Baba T., Shigematsu Y., Shiota H.,
RA   Ichiki Y., Yasuda M., Uramoto H., Hanagiri T., Yasumoto K.;
RT   "Identification of ribosomal protein L19 as a novel tumor antigen
RT   recognized by autologous cytotoxic T lymphocytes in lung
RT   adenocarcinoma.";
RL   Cancer Sci. 101:46-53(2010).
//
RX   PubMed=38639832; DOI=10.1007/s13577-024-01055-0; PMCID=PMC11194210;
RA   Kasai F., Fukushima M., Miyagi Y., Nakamura Y.;
RT   "Genetic diversity among the present Japanese population: evidence
RT   from genotyping of human cell lines established in Japan.";
RL   Hum. Cell 37:944-950(2024).
//